MetLife Investment Advisors LLC bought a new position in shares of Stericycle Inc (NASDAQ:SRCL) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 26,415 shares of the business services provider’s stock, valued at approximately $1,796,000.
Several other hedge funds and other institutional investors also recently modified their holdings of the business. Fuller & Thaler Asset Management Inc. boosted its position in shares of Stericycle by 500.0% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 3,000 shares of the business services provider’s stock worth $204,000 after buying an additional 2,500 shares in the last quarter. Balter Liquid Alternatives LLC purchased a new stake in shares of Stericycle in the 4th quarter worth about $206,000. Roberts Glore & Co. Inc. IL purchased a new stake in shares of Stericycle in the 4th quarter worth about $210,000. Investors Research Corp purchased a new stake in shares of Stericycle in the 4th quarter worth about $212,000. Finally, Allianz Asset Management GmbH purchased a new stake in shares of Stericycle in the 4th quarter worth about $229,000. Institutional investors own 94.28% of the company’s stock.
In related news, Director Jack W. Schuler acquired 10,000 shares of the company’s stock in a transaction dated Thursday, March 1st. The stock was bought at an average price of $62.59 per share, with a total value of $625,900.00. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 3.50% of the company’s stock.
Shares of SRCL stock opened at $58.07 on Friday. Stericycle Inc has a twelve month low of $56.64 and a twelve month high of $88.00. The stock has a market capitalization of $4,988.09, a P/E ratio of 13.38, a PEG ratio of 1.32 and a beta of 0.39. The company has a debt-to-equity ratio of 0.90, a current ratio of 0.84 and a quick ratio of 0.84.
Stericycle (NASDAQ:SRCL) last announced its earnings results on Wednesday, February 21st. The business services provider reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.14 by ($0.14). Stericycle had a net margin of 1.18% and a return on equity of 13.83%. The firm had revenue of $887.80 million during the quarter, compared to analyst estimates of $882.62 million. During the same period in the previous year, the firm posted $1.00 EPS. The company’s revenue for the quarter was down 2.1% compared to the same quarter last year. analysts expect that Stericycle Inc will post 4.58 EPS for the current year.
Several equities research analysts recently commented on the stock. Royal Bank of Canada decreased their price objective on shares of Stericycle from $75.00 to $61.00 and set an “underperform” rating on the stock in a research report on Thursday, February 22nd. BidaskClub upgraded shares of Stericycle from a “sell” rating to a “hold” rating in a research report on Wednesday, January 31st. Robert W. Baird upgraded shares of Stericycle from an “underperform” rating to a “neutral” rating and set a $73.00 price objective on the stock in a research report on Tuesday, February 13th. BMO Capital Markets reiterated a “hold” rating and issued a $72.00 price objective on shares of Stericycle in a research report on Wednesday, January 24th. Finally, Zacks Investment Research upgraded shares of Stericycle from a “sell” rating to a “hold” rating in a research report on Wednesday, January 10th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and five have assigned a buy rating to the stock. Stericycle presently has a consensus rating of “Hold” and an average target price of $70.67.
COPYRIGHT VIOLATION WARNING: This news story was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/04/07/metlife-investment-advisors-llc-invests-1-80-million-in-stericycle-inc-srcl.html.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.